The cellular composition of chronic subdural hematoma.

Cellular profile Inflammatory cells Personalized treatment Risk profile Subdural fluid

Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
10 May 2024
Historique:
received: 29 12 2023
accepted: 28 04 2024
medline: 10 5 2024
pubmed: 10 5 2024
entrez: 9 5 2024
Statut: epublish

Résumé

The pathophysiology of chronic subdural hematoma (CSDH) remains to be fully understood. Basic knowledge of the composition and features of cells in the CSDH fluid may contribute to the understanding of the seemingly complex processes involved in CSDH formation and recurrence. This study is the first to examine the composition of cells and of cellular features in both systemic blood and subdural fluid from CSDH patients. We hypothesized that the cellular composition and features in the hematoma fluid may be; 1) different from that in the systemic blood; 2) different between patients with and without recurrence; 3) and different between the first and second operation in patients with recurrent CSDH. Systemic blood and subdural hematoma fluid were collected from CSDH patients with and without recurrent CSDH at the time of primary and secondary surgery. Analyses of cells and cellular features included total number of white blood cells, erythroblasts, reticulocytes, platelets, neutrophilocytes, lymphocytes, monocytes, eosinophils, basophils, reticulocytes, immature granulocytes, mean corpuscular cell volume (MCV), mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, hemoglobin and hematocrit. Of the 85 included patients, 20 patients were operated for a recurrent CSDH within 90 days follow-up. All cells found in the systemic blood were present in the CSDH fluid, but the composition was different (p < 0.0001). MCV was higher in the hematoma fluid from the primary operation of patients later developing a recurrent CSDH compared to patients not developing recurrence (p = 0.009). Also, the percentage distribution of inflammatory cells in hematoma fluid from patients with recurrent CSDH was different between the first and second operation (p = 0.0017). This study is the first to investigate the cellular composition of CSDH fluid. Compared to systemic blood and to a reference distribution, an increased number of immune cells were present in the hematoma fluid, supporting an inflammatory component of the CSDH pathophysiology. MCV was higher in the subdural fluid at time of the first operation of CSDH patients later developing recurrence. The study was approved by the Scientific Ethical Committee of the Capital Region of Denmark (Journal no. H-20051073.

Identifiants

pubmed: 38724806
doi: 10.1007/s00701-024-06101-2
pii: 10.1007/s00701-024-06101-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

208

Informations de copyright

© 2024. The Author(s).

Références

Andersen-Ranberg NC, Poulsen FR, Bergholt B, Hundsholt T, Fugleholm K (2017) Bilateral chronic subdural hematoma: unilateral or bilateral drainage? J Neurosurg 126(6):1905–1911
doi: 10.3171/2016.4.JNS152642 pubmed: 27392267
Ansari-Lari MA, Kickler TS, Borowitz MJ (2003) Immature granulocyte measurement using the Sysmex XE-2100. Relationship to infection and sepsis. Am J Clin Pathol 120(5):795–799
doi: 10.1309/LT30BV9UJJV9CFHQ pubmed: 14608908
Arbiol-Roca A, Imperiali CE, Montserrat MM, Cerro AS, Bosch de Basea AC, Navarro LS, Dot Bach D, Politi JV (2018) Reference intervals for a complete blood count on an automated haematology analyser Sysmex XN in healthy adults from the southern metropolitan area of Barcelona. Ejifcc 29(1):48–54
pubmed: 29765286 pmcid: 5949618
Ayyildiz H, Karabulut N, Kalayci M (2018) Relationship between red blood cell distribution width and schizophrenia. Intl J Med Biochem 1(1):15–19
Cetın N, Kocaturk E, Tufan AK, Kıraz ZK, Alatas O (2023) Immature granulocytes as biomarkers of inflammation in children with predialysis chronic kidney disease. Pediatr Nephrol 38(1):219–225
doi: 10.1007/s00467-022-05530-4 pubmed: 35445974
Charlson ME, Carrozzino D, Guidi J, Patierno C (2022) Charlson Comorbidity Index: A Critical Review of Clinimetric Properties. Psychother Psychosom 91(1):8–35
doi: 10.1159/000521288 pubmed: 34991091
Doğan M, Gürleyen B (2022) The role of immature granulocyte in the early prediction of acute perforated and nonperforated appendicitis in children. Ulus Travma Acil Cerrahi Derg 28(3):375–381
pubmed: 35485560 pmcid: 10493542
Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 14(1):108
doi: 10.1186/s12974-017-0881-y pubmed: 28558815 pmcid: 5450087
Fan Y et al (2022) The inflammatory cellular feature in the peripheral blood of chronic subdural hematoma patients. J Clin Lab Anal 36(10):e24706
doi: 10.1002/jcla.24706 pubmed: 36114782 pmcid: 9551118
Jensen TSR, Andersen-Ranberg N, Poulsen FR, Bergholt B, Hundsholt T, Fugleholm K (2020) The Danish Chronic Subdural Hematoma Study-comparison of hematoma age to the radiological appearance at time of diagnosis. Acta Neurochir (Wien) 162(9):2007–2013
doi: 10.1007/s00701-020-04472-w pubmed: 32594246
Jensen TSR, Binderup T, Olsen MH, Kjaer A, Fugleholm K (2023) Subdural Levels of Interleukin 1-receptor Antagonist are Elevated in Patients with Recurrent Chronic Subdural Hematomas. Inflammation
Kara MZ, Kul M (2023) Can Red Blood Cell and Platelet Parameters Be Associated With Inflammation in Children With Tic Disorder? Cureus 15(10):e47280
pubmed: 37881325 pmcid: 10594065
L. van Pelt J, Klatte S, Hwandih T, Barcaru A, Riphagen IJ, Linssen J, Bakker SJL (2022) Reference intervals for Sysmex XN hematological parameters as assessed in the Dutch Lifelines cohort. 60(6): 907–920
Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70(7):663–671
doi: 10.1016/j.biopsych.2011.04.013 pubmed: 21641581 pmcid: 4071300
Monteiro WO, Bó SD, Farias MG, Castro SM (2021) Definition of Reference Range for the Immature Granulocytes Parameter Provided by a Hematology Analyzer. Clin Lab 67(1)
Müller W, Firsching R (1990) Significance of eosinophilic granulocytes in chronic subdural hematomas. Neurosurg Rev 13(4):305–308
doi: 10.1007/BF00346370 pubmed: 2280841
Park BH et al (2011) Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. BMC Infect Dis 11:299
doi: 10.1186/1471-2334-11-299 pubmed: 22040292 pmcid: 3213213
Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63(8):801–808
doi: 10.1016/j.biopsych.2007.09.024 pubmed: 18005941
Pripp AH, Stanišić M (2014) The correlation between pro- and anti-inflammatory cytokines in chronic subdural hematoma patients assessed with factor analysis. PLoS ONE 9(2):e90149
doi: 10.1371/journal.pone.0090149 pubmed: 24587250 pmcid: 3937441
Ransing RS, Patil S, Pevekar K, Mishra K, Patil B (2018) Unrecognized Prevalence of Macrocytosis among the Patients with First Episode of Psychosis and Depression. Indian J Psychol Med 40(1):68–73
doi: 10.4103/IJPSYM.IJPSYM_139_17 pubmed: 29403133 pmcid: 5795682
Rønn Jensen TS, Andersen-Ranberg N, Poulsen FR, Bergholt B, Hundsholt T, Fugleholm K (2018) [National guidelines for treatment of chronic subdural haematoma]. Ugeskr Laeger 180(42)
Sarkar C, Lakhtakia R, Gill SS, Sharma MC, Mahapatra AK, Mehta VS (2002) Chronic subdural haematoma and the enigmatic eosinophil. Acta Neurochir (Wien) 144(10): 983–988; discussion 988
Senthilnayagam BT, Kumar J, Sukumaran JM, Rao KR (2012) Automated measurement of immature granulocytes: performance characteristics and utility in routine clinical practice. Patholog Res Int 2012: 483670
Solak Y et al (2013) Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease. Nephrology (Carlton) 18(11):728–735
doi: 10.1111/nep.12130 pubmed: 23848392
Stanisic M et al. (2012) Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study. Acta Neurochir (Wien) 154(1): 113–120; discussion 120
Stanisic M et al (2012) Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study. Inflamm Res 61(8):845–852
doi: 10.1007/s00011-012-0476-0 pubmed: 22527446
Sucu HK, Gokmen M, Gelal F (2005) The value of XYZ/2 technique compared with computer-assisted volumetric analysis to estimate the volume of chronic subdural hematoma. Stroke 36(5):998–1000
doi: 10.1161/01.STR.0000162714.46038.0f pubmed: 15817899
Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240(4857):1285–1293
doi: 10.1126/science.3287615 pubmed: 3287615
Sørensen JB, Klee M, Palshof T, Hansen HH (1993) Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 67(4):773–775
doi: 10.1038/bjc.1993.140 pubmed: 8471434 pmcid: 1968363
Tseng JH, Tseng MY, Liu AJ, Lin WH, Hu HY, Hsiao SH (2014) Risk factors for chronic subdural hematoma after a minor head injury in the elderly: a population-based study. Biomed Res Int 2014:218646
doi: 10.1155/2014/218646 pubmed: 25295251 pmcid: 4180895
Yamashima T, Kubota T, Yamamoto S (1985) Eosinophil degranulation in the capsule of chronic subdural hematomas. J Neurosurg 62(2):257–260
doi: 10.3171/jns.1985.62.2.0257 pubmed: 3968565
Yamashima T, Yamamoto S (1984) How do vessels proliferate in the capsule of a chronic subdural hematoma? Neurosurgery 15(5):672–678
doi: 10.1227/00006123-198411000-00006 pubmed: 6209593
Zhang Y, Yang Y, Long S, Li G (2020) Assessment of peripheral blood cell inflammatory markers in patients with chronic subdural hematoma. Clin Neurol Neurosurg 191:105738
doi: 10.1016/j.clineuro.2020.105738 pubmed: 32087462

Auteurs

Thorbjørn Søren Rønn Jensen (TSR)

Department of Neurosurgery, The Neuroscience Centre, Copenhagen University Hospital, Inge Lehmanns Vej 6, 2100, Copenhagen, Rigshospitalet, Denmark. tjens07@gmail.com.

Markus Harboe Olsen (MH)

Department of Neuroanesthesiology, The Neuroscience Centre, Copenhagen University Hospital, Copenhagen, Rigshospitalet, Denmark.
Department of Anaesthesiology, Zealand University Hospital, Køge, Denmark.

Christina Christoffersen (C)

Department of Clinical Biochemistry, Copenhagen, Rigshospitalet, Denmark.

Tina Binderup (T)

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen, Rigshospitalet, Denmark.

Kåre Fugleholm (K)

Department of Neurosurgery, The Neuroscience Centre, Copenhagen University Hospital, Inge Lehmanns Vej 6, 2100, Copenhagen, Rigshospitalet, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH